Pharmacovigilance of Antimicrobial Drug: Azithromycin

Pharmacovigilance of antimicrobial drugs is critical for ensuring their safety and efficacy in clinical use. Azithromycin, a widely used macrolide antibiotic, is commonly prescribed for a variety of bacterial illnesses, such as respiratory and sexually transmitted diseases. Despite its general safety profile, concerns regarding adverse drug reactions (ADRs), resistance, and interactions with other drugs necessitate continuous monitoring. This review explores the pharmacovigilance data associated with Azithromycin, highlighting common and rare ADRs, such as gastrointestinal disturbances, cardiovascular effects, and potential risks in vulnerable populations. Moreover, the role of pharmacovigilance systems in detecting and managing these effects is emphasized, alongside the importance of post-marketing surveillance to assess long-term safety. Effective pharmacovigilance can guide healthcare professionals in optimizing treatment protocols and minimizing the risks of Azithromycin use, ensuring better patient outcomes and public health.